The bioInformatics segment, which is the
smallest of industry segments constituting barely two percent of the
market share in the overall industry revenue, grew by 4.95% in FY
2010-11. The segment clocked
242.43 crore in this fiscal as compared
231 crore in FY 2009-10. The major
players in the segment, Strand
Life Sciences and Ocimum Biosolutions collectively contributed
crore to the overall revenue.
The factors contributing to this growth include tracking of discovery
activities, data analysis, and pharma research. The different sub
verticals covered under it are Informatics, Omics, Lab information,
Clinical Data Management and Biostatistics.
Most of the companies in this segment are small-scale enterprises
located in cities such as Pune, Mumbai, Bangalore and Hyderabad.
Innovative companies such as Strand Life Sciences, Ocimum Biosolutions,
V Life Sciences, SysArris, Cell works, CytoGenomics and Molecular
Connections are working towards speeding up the cause of the core life
The segment is also getting a push with large IT companies such as
Cognizant, HCL, Wipro, TCS joining the fray. However, BioSpectrum
Survey 2011 does not include revenues of these IT companies in its
analysis, as that will skew the survey results.
The latest trends in the field that can contribute to the future growth
of the segment include translational bioinformatics, personalized
medicine and genomics. Next five years will see the sector wriggle out
of its current position and take the centerstage. Host of developments
are taking place in the genomics and molecular research that will
likely boost the bioinformatics industry. Significant advances in the
field of proteomics and related technologies will influence the way
research and diagnostic analysis are performed. With the increase in
R&D investments by various companies and the government support, it
is clear that in the years to come, the bioinformatics market will post
a steady growth.
During the year, Ocimum Biosolutions, a leading bioinformatics company
has closed funding worth $8 million from multiple sources, including
founders and existing shareholders, in order to cater to the growing
demand for its integrated genomic services and to provide unparalleled,
hassle-free user experience by enhancing its RaaS (Research as a
Service) platform. The company is in the process of building a
state-of-the art integrated campus in Patancheru, Hyderabad. Part of
the funds will be utilized into completing the 360,000 sq ft
facility spread across four blocks.
Ocimum started providing BioIT consulting services to enable R&D
for organizations in the life sciences industry. It also launched its
quantitative real-time polymerase chain reaction (qRT-PCR) services in
India. This technology is already in use at Gene Logic, an Ocimum
In the last quarter of 2010, Strand Life Sciences, another leading name
in the sector, announced the creation of a US-based subsidiary Strand
Scientific Intelligence, Inc (Strand SI) to commercialize its
innovative Scientific Intelligence solutions at the global level. The
company also announced the worldwide release of Avadis NGS, a software
application for next-generation sequence (NGS) analysis.
Top 3 BioInformatics Companies by
in Crore 2009-10
over 2009-10 (%)
over 2008-09 (%) 2011 (%)
||Strand Life Sciences